Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-02

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of Radion™-Pdt in oral precancerous lesions (erythroleukoplakia and verrucous hyperplasia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radion™-Pdt

Snippet

Sponsor: Pharma Power Biotec Co., Ltd. | Conditions: Erythroleukoplakia of Mouth, Verrucous Hyperplasia of Oral Mucosa | Phase 2 | Status: COMPLETED